tiprankstipranks
Satellos Bioscience Secures $40 Million Funding Boost
Company Announcements

Satellos Bioscience Secures $40 Million Funding Boost

Story Highlights

Satellos Bioscience (TSE:MSCL) has released an update.

Pick the best stocks and maximize your portfolio:

Satellos Bioscience successfully closed a $40 million public offering, issuing over 63 million equity securities, to fund its Phase 2 clinical program for SAT-3247. The offering was led by Bloom Burton Securities Inc. and participated by several agents. The funds will support clinical development and general corporate needs.

For further insights into TSE:MSCL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskSatellos Bioscience Announces Public Offering of Shares
TipRanks Canadian Auto-Generated NewsdeskSatellos Advances in Duchenne Muscular Dystrophy Trial
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App